ArticleEcancermedicalscience2025
Cross-sectional evaluation of a peer educator-led empowerment initiative for improving participation in cervical precancer screening among female sex workers in Ghana.
Article in Ecancermedicalscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cervical leukoplakia in Ghana: Unveiling diagnostic challenges and informing low-resource screening strategies.PloS one · 2026Observational
- Expanding access to HPV screening through community health insurance schemes: lessons from a screening exercise for teachers in Ghana.BMC health services research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Despite having an increased risk of HPV infection, female commercial sex workers (FCSWs) have low uptake of cervical screening. Among FCSWs in the Volta Region of Ghana referred for screening following peer education, we examined the prevalence of high-risk human papillomavirus (hr-HPV) and cervical lesions and modelled factors associated with these screening outcomes. Patients and methods: As part of the mPharma Ten Thousand Women Initiative, implemented between September and October 2022, 340 FCSWs in Ho and Aflao were recruited by peer educators. Screening involved MA-6000 testing (with full genotyping using the AmpFire HPV platform) and enhanced visual assessment (EVA) mobile colposcopy. Results: The FCSWs screened had a mean age of 31.9 (SD, 9.3) years. The prevalence of cervical lesions on mobile colposcopy was 9.8% (95% confidence intervals (CI), 4.9-14.7), while the prevalence of hr-HPV infection among the FCSWs was estimated at 28.0% (95% CI, 20.6-35.3). The commonest individual genotype was HPV68 (9.1%; 95% CI, 4.9-15.0), while the least common genotypes were HPV33 and HPV39 (each 0.7%; 95% CI, 0.0-3.8). FCSWs screened in Aflao maintained threefold higher odds of hr-HPV infection (aOR, 3.33; 95% CI, 1.18-9.40) and having clinically significant EVA findings was associated with approximately fivefold higher odds of hr-HPV infection (aOR, 4.64; 95% CI, 1.09-19.83; Conclusion: Our study underscores the urgent need for comprehensive and targeted interventions to reduce the burden of hr-HPV and the potential for cervical precancer/cancer among FCSWs in Ghana. We further highlight the importance of promoting continuous condom use among FCSWs during interactions with patrons and considering HIV status in the development and implementation of cervical precancer screening programs for FCSWs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.